Ventana
FDA approves first diagnostic tool to target triple-negative breast cancer patients
March 11, 2019Sales and Marketing Cancer, Roche, Ventana, breast cancer, pharma
Roche’s Ventana PD-L1 Assay has become the first FDA-approved companion diagnostic for the identification of patients with triple-negative breast cancer …
Boehringer and Ventana link up
September 24, 2013Research and Development, Sales and Marketing Boehringer, Ventana, oncology
Boehringer Ingelheim has signed a deal with Roche subsidiary Ventana Medical Systems to develop companion diagnostic tests for Boehringer’s oncology …
Roche investing $180m on US diagnostics facilities
October 18, 2010Research and Development Diagnostics, Roche, Ventana, personalised medicine
Swiss drugmaker Roche is planning to invest $180 million and boost staff at its diagnostics subsidiary Ventana Medical Systems, as …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
August 14, 2026
